Literature DB >> 28617558

Up-regulation of miR-124 inhibits invasion and proliferation of prostate cancer cells through mediating JAK-STAT3 signaling pathway.

Z Wu1, W Huang, B Chen, P-D Bai, X-G Wang, J-C Xing.   

Abstract

OBJECTIVE: Signal transducer and activator of transcription 3 (STAT3) is an important protein in Janus kinase (JAK)-STAT signaling pathway, and can facilitate expression of Bcl-2 and Cyclin D1 gene, thus playing a role in tumor pathogenesis. Bioinformatics analysis revealed targeted binding sites between mircroRNA-124 (miR-124) and 3'-UTR of STAT3 mRNA. This study aims to investigate the role of miR-124 in regulating STAT3 expression and proliferation, cycle, apoptosis and invasion of prostate cancer cells.
MATERIALS AND METHODS: Dual luciferase reporter gene assay demonstrated targeted correlation between miR-124 and STAT3. Expression of miR-124, STAT3, p-STAT3, Bcl-2 and Cyclin D1 was compared between normal human prostate epithelial cell RWPE-1 and prostate cancer cell DU145. In vitro cultured DU145 cells were treated with miR-124 mimic and/or si-STAT3, to compare expression of STAT3, phosphorylated STAT3 (p-STAT3), B-cell lymphoma-2 (Bcl-2) and Cyclin D1. Flow cytometry detected cell apoptosis and cycle, followed by clonal formation and transwell assay to test malignant proliferation and cell invasion.
RESULTS: Targeted regulation existed between miR-124 and STAT3. Comparing to RWPE-1, DU145 cells had lower miR-124 expression, G0/G1 phase ratio, or cell apoptosis, plus higher expression of STAT3, p-STAT3, Bcl-2 and Cyclin D1, ratio of S or G2/M phase. Transfection of miR-124 mimic and/or si-STAT3 remarkably decreased gene expression, weakened clonal formation, cell invasion, ratio of S and G2/M phase, cell apoptosis and increased G0/G1 ratio.
CONCLUSIONS: MiR-124 up-regulation significantly suppresses STAT3, pSTAT3 and downstream Bcl-2 and Cyclin D1 expression, weakens cell invasion or malignant proliferation potency, induces G0/G1 phase arrest, and facilitates cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28617558

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Influence of SIRT6 regulation of cellular glycometabolism on radiosensitivity of non-small-cell lung cancer A549 cells.

Authors:  Yong Cai; Zhaoying Sheng; Yun Chen; Jiying Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.

Authors:  Lingyang Xia; Peng Jin; Wei Tian; Shuang Liang; Liye Tan; Binxin Li
Journal:  Braz J Med Biol Res       Date:  2021-05-17       Impact factor: 2.590

3.  Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer.

Authors:  Fabiana Sélos Guerra; Daniel Alencar Rodrigues; Carlos Alberto Manssour Fraga; Patricia Dias Fernandes
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-21

4.  Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate.

Authors:  Julio Guilherme Balieiro Bernardes; Marianne Rodrigues Fernandes; Juliana Carla Gomes Rodrigues; Lui Wallacy Morikawa Souza Vinagre; Lucas Favacho Pastana; Elizabeth Ayres Fragoso Dobbin; Jéssyca Amanda Gomes Medeiros; Leonidas Braga Dias Junior; Gabriel Monteiro Bernardes; Izabel Maria Monteiro Bernardes; Ney Pereira Carneiro Dos Santos; Samia Demachki; Rommel Mario Rodriguez Burbano
Journal:  Genes (Basel)       Date:  2022-03-30       Impact factor: 4.141

5.  Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer.

Authors:  Ji Yeon Kim; Woo Jeong Lee; Ha Young Park; Ahrong Kim; Dong Hoon Shin; Chang Hun Lee
Journal:  J Pathol Transl Med       Date:  2018-08-16

6.  Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6.

Authors:  Dan Zhong; Xilin Lyu; Xiaohong Fu; Peng Xie; Menggang Liu; Fengtian He; Gang Huang
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

7.  Proscillaridin A induces apoptosis, inhibits STAT3 activation and augments doxorubicin toxicity in prostate cancer cells.

Authors:  Yangyang He; Muhammad Khan; Jingbo Yang; Min Yao; Shili Yu; Hongwen Gao
Journal:  Int J Med Sci       Date:  2018-05-22       Impact factor: 3.738

Review 8.  MicroRNA-124: An emerging therapeutic target in cancer.

Authors:  Xinqi Jia; Xu Wang; Xiaorong Guo; Jingjing Ji; Ge Lou; Junjie Zhao; Wenjia Zhou; Mian Guo; Maomao Zhang; Chao Li; Sheng Tai; Shan Yu
Journal:  Cancer Med       Date:  2019-08-06       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.